Novavax (MEX:NVAX) Cash Flow for Dividends : MXN0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Novavax Cash Flow for Dividends?

Novavax's cash flow for dividends for the three months ended in Dec. 2024 was MXN0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was MXN0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Novavax Cash Flow for Dividends Historical Data

The historical data trend for Novavax's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Cash Flow for Dividends Chart

Novavax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

Novavax Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Novavax Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

Novavax Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Novavax's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Novavax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (MEX:NVAX) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

NVAX:USA NVV1:Germany NVV1:Germany NVV1:Germany NVV1:Germany NVV1:Bulgaria NVAX:Austria

Address

700 Quince Orchard Road, Gaithersburg, MD, USA, 20878

Website

https://www.novavax.com

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.